Samuel Lunenfeld Research Institute, Mount Sinai Hospital
sinaihealth.caLive pipeline data from ClinicalTrials.gov, refreshed daily.
Total trials
134
Active
15
Phase 3
3
Total enrollment
10,579
Pipeline matrix
Showing 11 of 11 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Oxytocin | — | — | — | — | — | 25 | |
| Carbetocin | — | — | — | — | — | 14 | |
| Phenylephrine | — | — | — | — | 5 | ||
| Norepinephrine | — | — | — | — | — | 4 | |
| Ephedrine | — | — | — | — | — | 2 | |
| Ergonovine | — | — | — | — | — | 3 | |
| Carboprost | — | — | — | — | — | 3 | |
| Calcium | — | — | — | — | — | 2 | |
| Intrathecal morphine | — | — | — | — | — | 2 | |
| Calcium Chloride | — | — | — | — | — | 1 | |
| Vasopressin | — | — | — | — | — | 1 |
Next readouts
- 2026-06
- 2026-12
- 2026-12
- 2026-12
- 2026-12
- 2026-12
- 2026-12
- 2026-12
Top conditions
- Postpartum Hemorrhage29
- Labor Pain21
- Pain16
- Pregnancy12
- Hypotension7
- Obesity4
- Postpartum Hemorrhage (Primary)3
- Airway Complication of Anesthesia3
Frequently asked questions about Samuel Lunenfeld Research Institute, Mount Sinai Hospital
- How many clinical trials does Samuel Lunenfeld Research Institute, Mount Sinai Hospital have on ClinicalTrials.gov?
- Samuel Lunenfeld Research Institute, Mount Sinai Hospital is listed as the lead sponsor on 134 clinical trials in ClinicalTrials.gov, 15 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Samuel Lunenfeld Research Institute, Mount Sinai Hospital's trials are in Phase 3?
- 3 of Samuel Lunenfeld Research Institute, Mount Sinai Hospital's trials are in Phase 3, spread across 11 active drug programs.
- What therapeutic areas does Samuel Lunenfeld Research Institute, Mount Sinai Hospital focus on?
- Samuel Lunenfeld Research Institute, Mount Sinai Hospital's most-studied conditions on ClinicalTrials.gov are Postpartum Hemorrhage, Labor Pain, Pain, Pregnancy, Hypotension.
- When are Samuel Lunenfeld Research Institute, Mount Sinai Hospital's next clinical trial readouts?
- Samuel Lunenfeld Research Institute, Mount Sinai Hospital has 8 upcoming primary-completion readouts tracked here; the soonest is “Effect of Extracellular Calcium on Carbetocin Mediated Contractility in Human Myometrium”, expected around 2026-06.